Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
JNJ · against 1,329 other Healthcare companies
Ranked #428 of 1,330 · scores higher than 66% of peers
Bars: peers in each 10-point band of the overall score260 peers with an overall score of 50–59, including JNJ · Click a bar to see the companies
| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.0B EUR (≈$3.3B) | 99 | 100 | 100 | 0 / 2 | ||
| 2 | 658M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 2.0B USD | 97 | 97 | 99 | 93 | 0 / 2 | |
| 2 | 238M USD | 97 | 94 | — | 98 | 0 / 2 | |
| 5 | 16.7B DKK (≈$2.5B) | 96 | 96 | 99 | 96 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 428 | 7.8B HKD (≈$1.0B) | 59 | 80 | 28 | 0 / 2 |
| 428 | 1.0B NOK (≈$97M) | 59 | 44 | 36 | 60 | 0 / 2 |
| 428 | 12.1B USD | 59 | 76 | 58 | 84 | 2 / 2 |
| 428 | 588.2B INR (≈$7.1B) | 59 | 48 | 70 | 72 | 1 / 2 |
| 428 | 622.8B USD | 59 | 60 | 48 | 91 | 1 / 2 |
| 428 | 506M USD | 59 | 78 | 18 | 90 | 1 / 2 |
| 428 | 10.9B EUR (≈$11.9B) | 59 | 71 | 57 | 88 | 2 / 2 |
| 428 | 1.1B USD | 59 | 47 | 88 | 44 | 1 / 2 |
| 428 | 29.6B USD | 59 | 88 | 42 | 95 | 2 / 2 |